[ET Net News Agency, 5 March 2024] KEYMED BIO-B (02162) fell 9.6% to HK$32.6, dipping
below the 20-D SMA of HK$32.87.
It hits an intra-day low of HK$32.35, and an intra-day high of HK$35.25. The total
shares traded was 700,500, with a value of HK$23.42m. The active buy/sell ratio is 40:60,
with net selling turnover of HK$4.77m. JEFFERIES HK accounts for greatest net responsive
buying turnover of HK$2.77m, with volume weighted average price of HK$33.322. GOLDMAN
SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$1.33m, with
volume weighted average price of HK$33.298.

Basic Information
=================

----------------------------------
Nominal 32.600 % Chg -9.57%
High 35.250 Low 32.350
Shares Tr 700,500 Turnover 23.42m
10-D SMA 34.170 %H.V 71.769
20-D SMA 32.870 VWAP 33.437
50-D SMA 36.667 RSI14 44.877
----------------------------------
Status: Dipping below the 20-D SMA, active buy/sell ratio is 40:60, with net selling
turnover of HK$4.77m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 32.60 -9.57
HUTCHMED (00013) 22.85 -6.16
GENSCRIPT BIO (01548) 15.10 -4.31
INNOVENT BIO (01801) 40.05 -3.96
EVEREST MED-B (01952) 24.20 -1.43
WUXI XDC (02268) 23.05 -1.07
WUXI BIO (02269) 20.20 -3.81
BEIGENE (06160) 99.50 +0.10
SKB BIO-B (06990) 123.80 +3.17
AKESO (09926) 45.30 -4.83
---------------------------------------------
(ed)